Religare Health Trust (“RHT”) is the first business trust listed on
the Singapore Exchange Securities Trading Limited (“SGX-ST”)
with India based healthcare assets.
Our investment mandate is principally to invest in medical and
healthcare assets and services in Asia, Australasia and emerging
markets in the rest of the world. RHT may also develop medical
and healthcare assets.
RHT has a portfolio of strategically located Clinical
Establishments* and Operating Hospitals across India, currently
comprising 12 Clinical Establishments, 4 Greenfield Clinical
Establishments and 2 Operating Hospitals. The value of these
assets is approximately S$991 million
^
as at 31 March 2015.
About
Religare
Health
Trust
*
Clinical Establishment refers to a fully
centrally air-conditioned institution
established and specifically customised and
fitted with all fixtures, fittings, medical
equipment and infrastructure required for
running and operating a hospital, offering:
(1) services for diagnosis and treatment
for illness, disease, injury, deformity and/
or abnormality; (2) diagnosis of diseases
through radiological and other diagnostic
and investigative services with the aid or
laboratory or other medical equipment;
and (3) beds for in-patient treatment.
^
based on exchange rate of S$1 = INR 45.43
as at 31 March 2015.
We endeavor to provide regular and
stable returns to investors by investing into
healthcare assets providing attractive yields
with a potential for long term growth.
Geographically
Diversified
Asset Portfolio
24
Portfolio
Summary
26
Corporate
Governance
Report
Annual
Financial
Statements
41
57
Statistics of
Unitholdings
125
CONTENTS
Trust
Structure
Financial
Highlights
Performance
Highlights
Financial and
Operational
Review
3
4 5
7
Capital Risk
Management
8
Market Review
and Outlook
Growth
Strategy
Organisation
Chart
Letter to
Unitholders
9 12 13 14
Board of
Directors
16
Religare Health
Trust Senior
Management
Team
Corporate
Sustainability
Report
Significant
Events
Senior
Management
of the Trustee-
Manager
18 18 20 22
Notice of Annual
General Meeting
of Unitholders
127
Corporate
Information
130
Proxy Form
